Argenica Therapeutics Limited (ASX:AGN)
Australia
· Delayed Price · Currency is AUD
0.200
-0.020 (-9.09%)
Mar 10, 2026, 9:59 AM AEST
Argenica Therapeutics Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Other Revenue | 1.01 | 3.21 | 2.6 | 1.75 | 0.26 | 0.3 | |
| Revenue | 1.01 | 3.21 | 2.6 | 1.75 | 0.26 | 0.3 | |
| Revenue Growth (YoY) | -67.31% | 23.70% | 48.46% | 575.38% | -12.49% | - | |
| Gross Profit | 1.01 | 3.21 | 2.6 | 1.75 | 0.26 | 0.3 | |
| Selling, General & Admin | 2.84 | 2.65 | 2.11 | 1.86 | 1.43 | 0.64 | |
| Research & Development | 8.25 | 8.13 | 6.02 | 4.31 | 2.5 | 0.42 | |
| Operating Expenses | 11.14 | 10.9 | 8.27 | 6.62 | 4.35 | 1.33 | |
| Operating Income | -10.13 | -7.68 | -5.67 | -4.87 | -4.09 | -1.03 | |
| Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 | |
| Interest & Investment Income | 0.33 | 0.51 | 0.19 | 0.06 | 0 | 0 | |
| Pretax Income | -9.8 | -7.17 | -5.48 | -4.82 | -4.09 | -1.03 | |
| Income Tax Expense | - | - | - | - | - | 0 | |
| Net Income | -9.8 | -7.17 | -5.48 | -4.82 | -4.09 | -1.03 | |
| Net Income to Common | -9.8 | -7.17 | -5.48 | -4.82 | -4.09 | -1.03 | |
| Shares Outstanding (Basic) | 129 | 128 | 104 | 74 | 74 | 35 | |
| Shares Outstanding (Diluted) | 129 | 128 | 104 | 74 | 74 | 35 | |
| Shares Change (YoY) | 9.73% | 22.97% | 40.29% | - | 108.80% | 112.54% | |
| EPS (Basic) | -0.08 | -0.06 | -0.05 | -0.07 | -0.06 | -0.03 | |
| EPS (Diluted) | -0.08 | -0.06 | -0.05 | -0.07 | -0.06 | -0.03 | |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | |
| Operating Margin | -1006.58% | -239.05% | -218.30% | -278.59% | -1579.49% | -347.76% | |
| Profit Margin | -973.56% | -223.12% | -210.92% | -275.16% | -1578.84% | -347.72% | |
| EBIT | -10.13 | -7.68 | -5.67 | -4.87 | -4.09 | -1.03 | |
| EBIT Margin | - | -239.05% | -218.30% | -278.59% | - | - | |
| Revenue as Reported | 1.34 | 3.73 | 2.79 | 1.81 | 0.26 | 0.3 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.